October 18 2018 - Novartis buys Endocyte for $2.1 billion

October 18 2018 - Novartis buys Endocyte for $2.1 billion

Novartis buys Endocyte for $2.1 billion
Merck’s Keytruda ready to challenge Bristol in kidney cancer
Pfizer confirms 2% of workforce to be cut
AbbVie commits $100 million to Morphic in fibrosis R&D alliance
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

Today's most popular searches:

For banking news and anonymous forums, be sure to check out cafebanking.com

image: